SCHEMBL21452830

SCHEMBL21452830

CN[C@H]1CC[C@@H](NC(C)=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.50
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
TLR4 O00206 1/20 0.42
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
FASN P49327 1/20 0.39
KDM1A O60341 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALOX15 P16050 1/20 0.33
DRD2 P14416 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
EPHX2 P34913 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13866437 1.00 ATM (0.50) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL14922428 0.91 ALDH1A1 (0.53) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL18502884 0.91 ALDH1A1 (0.53) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL23352154 0.90 ATM (0.46) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL10245502 0.86 ATM (0.48) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL20912045 0.86 ATM (0.54) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL21452802 0.86 ATM (0.48) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL17780153 0.86 ATM (0.54) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL21452879 0.86 ATM (0.54) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL15765690 0.86 ATM (0.48) ATMALDH1A1KDM4ETLR4MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 WO disclosed